- Home
- EVAX vs SOS Comparison
EVAX vs SOS Comparison
Compare EVAX & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- SOS
- Stock Information
- Founded
- EVAX 2008
- SOS 2004
- Country
- EVAX Denmark
- SOS China
- Employees
- EVAX N/A
- SOS N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SOS Finance: Consumer Services
- Sector
- EVAX Health Care
- SOS Finance
- Exchange
- EVAX Nasdaq
- SOS Nasdaq
- Market Cap
- EVAX 14.3M
- SOS 14.1M
- IPO Year
- EVAX 2021
- SOS 2017
- Fundamental
- Price
- EVAX $1.37
- SOS $8.29
- Analyst Decision
- EVAX Strong Buy
- SOS
- Analyst Count
- EVAX 2
- SOS 0
- Target Price
- EVAX $11.00
- SOS N/A
- AVG Volume (30 Days)
- EVAX 40.9K
- SOS 49.5K
- Earning Date
- EVAX 10-31-2024
- SOS 11-26-2024
- Dividend Yield
- EVAX N/A
- SOS N/A
- EPS Growth
- EVAX N/A
- SOS N/A
- EPS
- EVAX N/A
- SOS N/A
- Revenue
- EVAX $3,295,000.00
- SOS $111,124,000.00
- Revenue This Year
- EVAX $4,845.21
- SOS N/A
- Revenue Next Year
- EVAX $30.30
- SOS N/A
- P/E Ratio
- EVAX N/A
- SOS N/A
- Revenue Growth
- EVAX N/A
- SOS N/A
- 52 Week Low
- EVAX $1.28
- SOS $7.23
- 52 Week High
- EVAX $13.61
- SOS $103.20
- Technical
- Relative Strength Index (RSI)
- EVAX 22.79
- SOS 37.51
- Support Level
- EVAX $1.28
- SOS $7.23
- Resistance Level
- EVAX $1.80
- SOS $15.00
- Average True Range (ATR)
- EVAX 0.27
- SOS 1.69
- MACD
- EVAX -0.10
- SOS -0.42
- Stochastic Oscillator
- EVAX 6.08
- SOS 13.64
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.